Effects of paroxetine, ketoconazole, and rifampin on the metabolism of eliglustat, an oral substrate reduction therapy for Gaucher disease type 1
| Autor: | Vu, Lucie, Cox, Gerald F., Ibrahim, Jennifer, Peterschmitt, M. Judith, Ross, Leorah, Thibault, Nathan, Turpault, Sandrine |
|---|---|
| Zdroj: | In Molecular Genetics and Metabolism Reports March 2020 22 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|